Psilera, a US-based biotechnology company, announced on Tuesday that it has named Magali Haas, MD, PhD as its new director.
Presently, Dr Haas works as founder and chair of Cohen Veterans Bioscience and has earlier served as CEO & president for ten years. She has set up Brain Health Nexus, a global initiative focused on operationalising brain health through the development, validation and adoption of a global brain health index.
Dr Chris Witowski, Psilera CEO, said: "We are thrilled to welcome Magali as an independent member of our board of directors. Her extensive background in neuroscience and experience translating early-stage research and clinical development align perfectly with our mission at Psilera."
Rarity Health named finalist for 21st MM+M Rare Disease Agency of the Year
AxoSim names new vice president of Sales and Marketing
Kyverna Therapeutics names new CEO and board member
Anervea.ai names new chief commercial officer and board member